Β‑blockers Inhibit the Viability of Breast Cancer Cells by Regulating the ERK/COX‑2 Signaling Pathway and the Drug Response Is Affected by ADRB2 Single‑nucleotide Polymorphisms
Oncology Reports - Greece
doi 10.3892/or.2018.6830
Full Text
Open PDFAbstract
Available in full text
Date
October 29, 2018
Authors
Publisher
Spandidos Publications